Since she is doing God's will it is no surprise that Julie Meyer MBE is an individual authorised by the FCA to conduct investment business. But for how long? I have passed on all of my articles on Ms Meyer, covering the shocking administration of Ariadne Capital Ltd, ludicrous related party deals benefiting Ms Meyer by screwing her fund, dodgy accounting, unpaid bills, lying to potential investors about "cash in the bank" etc etc etc.

I am really warming to analyst Anne Stevenson-Yang of JCap whose latest note on Neil Woodfords pals at IP Group (IPO) "Some Companies deserve to die" is a stormer. And she cites the great work done by Shareprophet (sic) in her report.

IP-based pay-TV services technologies company Amino (AMO) has announced results for its year ended 30th November 2017 and that “Amino has made a promising start to 2018… the board expects the company to deliver sustainable profitable growth in the coming year”. The shares have responded, er, more than 4% lower further below 200p. Hmmm…

One wonders what Neil Woodford has been doing in the face of Cynical Bear’s onslaught against his funds. Reading Cynical’s pieces, it is clear that the Woodford house was edging ever closer to disaster. Now it seems that the effluent is indeed in collision with the air conditioning: we’ve had disasters at Purplebricks (PURP) and Capita  (CPI), and there’s a stockmarket correction (at least we hope that’s all it is) underway. Oh, and we have numbers from the AA on Thursday – hardly the ideal time to take a hatchet to its dividend! So what has Mr Woodford been up to? Well, why change a winning formula!

Hello, Share Monkeys. As this stupendous website’s raging bull, I feel it my duty to put the recent Wall Street-induced crash into perspective. In my view, based on long experience, there’s no need to be concerned. I’ve seen it all before - many times.

Interior furnishings company Walker Greenbank (WGB) “is pleased to announce a trading update for the year ended 31 January 2018” and emphasises “sales for the year are expected to be up 17.9% at £108.9 million”. Sounds promising…

If devout Christian Julie Meyer MBE does not like FACT based articles about her and Ariadne Capital Limited ( now in administration) by City AM, The Evening Standard, The Times, ShareProphets ( an avalanche) and ex employees turned whistleblower such as John Galt posting on LinkedIn she could always send yet another fascist lawyers letter to them. But since all that has been written has been based on fact....

Leisure, retail and care sector professional business services group Christie (CTG) has updated including “second half trading has been stronger than the first-half, and the 2017 full year results are expected to represent a significant improvement on the previous year”. However, I note a current just over 100p share price compares to more than 150p in early 2016. Hmmm…

I’m not normally one for emotive comment but my “Big Short” thesis at Woodford Patient Capital Trust (WPCT) is playing out almost exactly as I anticipated, albeit more quickly than I imagined, and it is an absolute scandal, make no mistake. All shareholders should be seeking redress and recompense immediately. Let me explain.

Well it is not really a crash yet, whatever the fake news media say as they try to blame Brexit or Trump. But it could be. So why are shares falling and should you buy, sell or hold? All of this as well as some stock specific observations are made in this bearcast as I prepare to head to London to see my daughter portray Harold Wilson.

One of Warren Buffett’s favourite maxims is to be greedy when others are fearful and fearful when others are greedy.

Premaitha Health (NIPT) has announced that its IONA test has been approved by Brazil's regulatory authority, Agência Nacional de Vigilância Sanitária (ANVISA), for sale as an in vitro diagnostic test.

As we await today's NAV from, deep in the merde, Woodford Patient Capital Trust (WPCT) as well as possible confirmation its unquoted holdings have surged through the 80% limit as well as potentially news on how close hitis to breaching the bank limit of 20% gearing, it is worth reminding ourselves of one reason why it is in this mess - its high risk approach to leverage. 

I know, I know, you have bigger matters to worry about with the current bout of stock market volatility impacting your wealth. It impacts mine too - especially the 6% fall of my largest holding Randgold Resources (RRS) after a full year results publication that saw record production, lower cash costs, fantastic grade, super sounding prospects... I could go on but regular readers know that I have an almost perma love-up with the FTSE-350's largest pure-play gold producer.

Writing on Accrol Group (ACRL) previously last month, business and management flux saw me remain sceptical. Now a Board Changes announcement…

Hello Share Mashers. After a lot of research and getting three-quarters of the way through a blistering piece on a firm which services other companies, I suddenly had a feeling that the shares would struggle to rise. I was unable to pin down creeping doubt, after my initial enthusiasm, but I abandoned the tip, anyway. Four hours work up the spout! But that’s the worth of this splendid website. We writers like to think we say stuff with real value and integrity. What's a few hours wasted, if we stand a better chance of making you some money? So instead I commend for your further attention a keep-fit enterprise.

As predicted here at the weekend Nasdaq listed Irish biotech Prothena (US:PRTA) is suffering a bloodbath today following the shock after hours resignation of its CMO on Friday. Shares in Purplebricks (PURP) are also crashing and that leaves the Woodford Patient Capital Trust (WPCT) in serious trouble - has it breached its banking limits yet?

In the wake of the recent fund raise by Obtala (OBT), the company's house broker VSA has slashed its price target from 36p to 25p but it is forecasting EPS of 1.6p for calendar 2018 and with massive asset backing, explains in a detailed note out today, why the shares will double from the current  12.625p mid. We own the shares and, for what it is worth, I agree with analyst Edward Hugo.

Secure payment and customer contact technology company Eckoh (ECK) is “very pleased with the recent progress we have made in the UK”, this including that it “has since interim results on November 22nd 2017 secured six sizeable UK contract wins across the payments, insurance, healthcare and mobile telecoms sectors - the latter being a contract with one of the UK's largest mobile network providers”. Significant growth ahoy then? Er…

If history is any guide, the good times are about to end for the U.S. stock market and it’s been one of the longest-running bull markets ever. Over nearly nine years, or 105 months, the S&P 500 has returned 368 percent (including dividends). That’s the second-longest bull market the U.S. has ever seen… just behind the nearly 9.5 year-long, or 113 months, bull market that started in 1990. You can see the S&P 500’s past bull markets in the table below… it shows the date they began, their overall return and how long each lasted. On average since 1926, bull markets have lasted for 54 months, and resulted in returns of 160 percent.